Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...

One million people in the UK have dementia and it already kills more people than cancer or heart disease - usually from ...

Patients with MCI, regardless of subtype, have a higher risk of developing hypertension, diabetes, and hyperlipidemia than cognitively normal individuals.

Neflamapimod is an oral p38 alpha kinase inhibitor that targets dysfunction and degeneration of acetylcholine-producing ...

Dementia is an umbrella term that describes multiple forms of cognitive impairment, including Alzheimer’s disease (the most common form of dementia), vascular dementia and Parkinson’s, according to ...

Scheduled for Second Half of January -PURCHASE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing ...

Find out more about how dementia biomarkers in blood tests can predict early cognitive decline and disease progression.

Experts say that nearly half of dementia cases are preventable—here's what you can do now to protect your brain in the future ...

Implications Beyond ALS The shared protein-misfolding pathology across neurological disorders suggests BTT’s intelligent programmed fever therapy can be utilized for the treatment of other ...

BTT Medical Institute Announces Unprecedented Case of Total Reversal of ALS through Re-engineering of the Nobel Prize-Winning Fever Therapy into a Brain-Guided, Artificial Intelligence-Controlled ...